PMC7425251_01
Hematoxylin and eosin-stained breast specimen showing normal-appearing tissue with predominant fibrous interlobular stroma and a paucity of adipose tissue (A). Higher magnification showing several acini and ductules with intralobular connective tissue within the breast lobule (B).
10.1177_2324709620949325-fig1.jpg
PMC7425251_01_10.1177_2324709620949325-fig1.jpg
fig1-2324709620949325
Pathology revealed dense fibrotic breast tissue with no features of malignancy (Figure 1).
Caudocranial view of contrast-enhanced magnetic resonance imaging of breasts with T2-weighted sequences showing edema of skin, subcutaneous, and glandular tissue markedly pronounced right breast greater than left.
10.1177_2324709620949325-fig2.jpg
PMC7425251_01_10.1177_2324709620949325-fig2.jpg
fig2-2324709620949325
A breast magnetic resonance imaging showed bilateral inflammatory changes and band-like focal edema at the 12 o'clock position of the right breast (Figure 2).
Pictured is the right breast (top row) and left breast (bottom row) at 2 weeks (A), 4 weeks (B), 6 weeks (C), and 7 weeks (D) after initiation of prednisone. Sloughing of the right eschar can be seen at 7 weeks with fatty, stromal tissue appearing underneath.
10.1177_2324709620949325-fig3.jpg
PMC7425251_01_10.1177_2324709620949325-fig3.jpg
fig3-2324709620949325
In the clinic, she complained of worsening breast pain, progressive lesions that have scabbed over, and scant discharge (Figure 3).
Thyroid function tests as a response to adjustments in levothyroxine.
10.1177_2324709620949325-fig4.jpg
PMC7425251_01_10.1177_2324709620949325-fig4.jpg
fig4-2324709620949325
Her levothyroxine dose was increased, and thyroid function tests and elevated prolactin levels were continuously monitored to normalization (Figures 4 and 5).
Serum prolactin level as a response to adjustments in levothyroxine.
10.1177_2324709620949325-fig5.jpg
PMC7425251_01_10.1177_2324709620949325-fig5.jpg
fig5-2324709620949325
Her levothyroxine dose was increased, and thyroid function tests and elevated prolactin levels were continuously monitored to normalization (Figures 4 and 5).